Financial statements Multi-Pharm
Cash inflows of MULTI-PHARM
| Year | 
                                    2018
                                                                     | 
                                    2019
                                                                     | 
                                    2020
                                                                     | 
                                    2021
                                                                     | 
                                    2022
                                                                     | 
                                    2023
                                                                     | 
|---|---|---|---|---|---|---|
| Net cash from operating expenses | 297 909,80 | -169 734,17 | 297 538,33 | -243 530,99 | 75 694,40 | 527 945,44 | 
| Net cash flow from investing activities | -17 486,33 | 0,00 | 0,00 | -486,99 | 0,00 | 0,00 | 
| Net cash flow from financial activities | -70 000,00 | 0,00 | 0,00 | 28 500,00 | -18 000,00 | 0,00 | 
| Total net cash flow | 210 423,47 | -169 734,17 | 297 538,33 | -215 517,98 | 57 694,40 | 527 945,44 | 
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
                    